168 related articles for article (PubMed ID: 8944429)
1. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
[TBL] [Abstract][Full Text] [Related]
2. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
3. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
5. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
[TBL] [Abstract][Full Text] [Related]
6. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
7. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the phenotype pattern of macrophages isolated from malignant and non-malignant pleural effusions.
Kaczmarek M; Nowicka A; Kozłowska M; Zurawski J; Batura-Gabryel H; Sikora J
Tumour Biol; 2011 Dec; 32(6):1123-32. PubMed ID: 21809139
[TBL] [Abstract][Full Text] [Related]
9. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
10. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719
[TBL] [Abstract][Full Text] [Related]
11. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease.
Budna J; Spychalski Ł; Kaczmarek M; Frydrychowicz M; Goździk-Spychalska J; Batura-Gabryel H; Sikora J
Immunobiology; 2017 Mar; 222(3):499-505. PubMed ID: 27773662
[TBL] [Abstract][Full Text] [Related]
13. Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
Chen Y; Liang B; Zhao YJ; Wang SC; Fan YB; Wu GP
Diagn Cytopathol; 2012 Apr; 40(4):287-91. PubMed ID: 22431315
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas.
Sasaki JI; Tanabe KK; Takahashi K; Okamoto I; Fujimoto H; Matsumoto M; Suga M; Ando M; Saya H
Int J Oncol; 1998 Mar; 12(3):525-33. PubMed ID: 9472088
[TBL] [Abstract][Full Text] [Related]
15. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
16. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
17. Expression of human CD44v6 in non-small-cell lung cancer.
Carbognani P; Spaggiari L; Romani A; Solli P; Corradi A; Cantoni AM; Petronini PG; Borghetti AF; Rusca M; Bobbio P
Eur Surg Res; 1998; 30(6):403-8. PubMed ID: 9838232
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 splice variants in metastatic and non-metastatic mouse tumour cell lines.
Tkach T; Li E; Bestagno M; Burrone OR
Immunol Lett; 1996 Sep; 52(2-3):81-7. PubMed ID: 8905400
[TBL] [Abstract][Full Text] [Related]
19. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
